Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Share Buyback Program

19 Dec 2025 07:21

RNS Number : 2789M
Banco Bilbao Vizcaya Argentaria SA
19 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

Further to the notice of inside information of 16 October 2025, with CNMV registration number 2942, BBVA has received the required authorization from the European Central Bank for the buyback and cancellation of own shares of BBVA for a maximum aggregate amount of 3,960 million euros, in one or several tranches and until 8 December 2026 (the "Authorization"). The maximum amount of 3,960 million euros has been fully deducted from BBVA's individual and consolidated common equity tier 1 (CET1) as from the Authorization receipt.

 

Once the Authorization has been obtained, and in exercise of the authority delegated to it by the Annual Shareholders' Meeting of BBVA held on 18 March 2022, the Board of Directors of BBVA, in its meeting held on 18 December 2025, has agreed to carry out a program scheme for the buyback of own shares in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016 (together the "Regulations"), which will be executed in several tranches, for a maximum aggregate amount of up to 3,960 million euros, aimed at reducing BBVA's share capital (the "Program Scheme"), notwithstanding the possibility to suspend or early terminate the Program Scheme upon the occurrence of circumstances that make it advisable.

 

Likewise, the Board of Directors has agreed, within the scope of the Program Scheme, to carry out a first tranche in accordance with the provisions of the Regulations with a view to reducing the share capital of BBVA (the "First Tranche") and with the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by cancelling the shares acquired.

 

Maximum cash amount:

 

The maximum aggregate cash amount will be 1,500,000,000 euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired will be 557,316,433.

 

Start of the execution:

Execution will start on 22 December 2025.

End of the execution:

The First Tranche will end neither before 6 March 2026 nor later than 7 April 2026[1] and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend execution of the First Tranche or end it early in the event of any circumstance that so advises or requires.

 

Trading Venues:

Purchases shall be made on the Spanish electronic trading system - Continuous Market and on the Cboe Europe, Turquoise Europe and Aquis Exchange trading platforms.

 

Manager:

The First Tranche will be executed externally through J.P. Morgan SE, which will decide independently of the Company on the timing of the purchases of BBVA shares.

 

Minimum Number of Shares Per Day

The Manager shall purchase at least 500,000 BBVA shares on each Trading Day (which is not an Excluded Day nor a Disrupted Day[2]), unless the Manager determines that it would not be possible to achieve the Minimum Number of Shares Per Day without breaching the restrictions and limitations under Delegated Regulation (EU) 2016/1052. Any such occurrence shall be duly disclosed in the periodic communications made in accordance with the Regulations, stating the reason why the Minimum Number of Shares Per Day was not purchased.

 

Other conditions:

The own shares will be purchased observing in all cases the conditions and limits established in the Regulations.

 

The share purchase transactions performed, as well as the end or, as the case may be, the temporary suspension of execution of the First Tranche, will be duly communicated in accordance with the Regulations.

 

 

Madrid, 19 December 2025


[1] However, for each "Excluded Day," the execution period may be postponed by one "Trading Day," up to a maximum postponement until 21 April 2026.

 

A "Trading Day" means each day on which the Continuous Market is scheduled to be open for trading during normal market hours.

 

An "Excluded Day" means any Trading Day on which: (i) any Trading Venue does not open for the entire regular trading session; or (ii) a suspension or limitation on the trading of BBVA shares is imposed on any Trading Venue for the entire regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for the entire regular trading session; or (iv) the Company has suspended the execution of the First Tranche.

 

[2] "Disrupted Day" means any Trading Day on which: (i) any Trading Venue is closed for a substantial part of its regular trading session or closes significantly earlier than its scheduled closing time, or there is a significant disruption to trading on any Trading Venue; or (ii) any Trading Venue imposes a suspension or limitation on the trading of BBVA shares for a substantial part of the regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for a substantial part of the regular trading session.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKABRVWUUARA
Date   Source Headline
31st Oct 20197:00 amRNS3Q19 Results Press Release
21st Oct 20195:05 pmRNS3Q19 Results Presentation Announcement
8th Oct 20197:41 amRNSCorporate Transactions
3rd Oct 20197:00 amRNSDividend October 2019
30th Sep 20197:00 amRNSRelevant Information DCN
24th Sep 20198:15 amRNSPre-Stabilisation Notice - BBVA
29th Aug 20197:00 amRNSOffer of securities contingently convertible
28th Aug 20197:00 amRNSPreferred securities contingently convertible
8th Aug 20197:00 amRNSSale of BBVA Paraguay
5th Aug 201912:07 pmRNSPost-Stabilisation Notice - BBVA
31st Jul 20198:18 amRNS2Q19 Results Report
31st Jul 20198:14 amRNS2Q19 Results Presentation
31st Jul 20197:08 amRNS2Q19 Results Press Release
18th Jul 20195:32 pmRNS2Q19 Results Presentation Announcement
4th Jul 20195:19 pmRNSFitch Ratings upgrade
21st Jun 20195:25 pmRNSTransfer of credits rights
12th Jun 20198:03 amRNSPre-Stabilisation Notice - BBVA
29th Apr 20195:24 pmRNSAppointments at the board of Directors
29th Apr 20195:20 pmRNS1Q19 Results Presentation
29th Apr 20195:08 pmRNS1Q19 Results Press Release
29th Apr 20195:06 pmRNS1Q19 Results Report
26th Apr 201910:41 amRNS2018 Audited Financial Statements
25th Apr 201910:48 amRNSPost Stabilisation Notice
17th Apr 201910:48 amRNS1Q19 Results Presentation Announcement
12th Apr 20197:00 amRNSGlobal Medium Term Programme - Venue change
20th Mar 201910:52 amRNSPost Stabilisation Notice - BBVA
20th Mar 20197:00 amRNSIssue of securities convertible into BBVA shares
19th Mar 201910:42 amRNSPre Stabilisation Notice
18th Mar 20193:42 pmRNSPrudential Relevance Report Pillar III in 2018
18th Mar 20193:36 pmRNSResolutions adopted by the AGM
20th Feb 20197:00 amRNSRedemption of Subordinated Notes
15th Feb 20197:00 amRNSCapital Requirements for 2019
13th Feb 20198:02 amRNS2019 AGM Proposed Resolutions
12th Feb 20197:00 amRNSFinal dividend calendar 2018
11th Feb 20196:07 pmRNS2019 Annual General Meeting Call
1st Feb 20197:00 amRNSFinal dividend for 2018
1st Feb 20197:00 amRNS4Q18 Results Presentation
1st Feb 20197:00 amRNS4Q18 Results Report
1st Feb 20197:00 amRNS4Q18 Results Press Release
28th Jan 20195:38 pmRNS4Q18 Results Presentation Announcement
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
27th Dec 20187:00 amRNSAgreement with Voyager Investing UK Limited
24th Dec 20187:00 amRNSBBVA gives full effect to its succession plan
21st Dec 20187:00 amRNSSuccession plans for Executive Chairman and CEO
20th Dec 20187:00 amRNSEstrategy automobile financing business in Chile
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.